rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Shukra Pharmaceuticals Ltd. - Research Center
524632 SHUKRAPHAR Group (XT) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Sources of funds
Owner's fund
Equity share capital 3.91 1.57 1.57 1.57 1.57
Share application money - - - - -
Preference share capital - - - - -
Reserves & surplus 21.38 14.78 14.03 13.85 13.81
Loan funds
Secured loans 1.31 0.25 - - -
Unsecured loans 3.77 3.13 9.77 8.05 6.06
Total 30.38 19.73 25.37 23.46 21.43
Uses of funds
Fixed assets
Gross block 41.22 35.08 17.69 33.40 28.51
Less : revaluation reserve - - - - -
Less : accumulated depreciation 20.99 17.50 - 16.02 12.90
Net block 20.23 17.58 17.69 17.38 15.60
Capital work-in-progress 1.66 1.66 1.66 1.66 1.66
Investments - 0.20 0.19 0.05 0.05
Net current assets
Current assets, loans & advances 53.07 15.67 15.22 14.45 11.07
Less : current liabilities & provisions 44.59 15.39 9.39 10.08 6.96
Total net current assets 8.48 0.28 5.82 4.37 4.12
Miscellaneous expenses not written - - - - -
Total 30.38 19.73 25.37 23.46 21.43
Notes:
Book value of unquoted investments - 0.20 0.19 0.05 0.05
Market value of quoted investments - - - - -
Contingent liabilities 1.40 - - - -
Number of equity sharesoutstanding (Lacs) 109.60 15.66 15.66 15.66 15.66
Close
Add Shukra Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Shukra Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close